NEW YORK (GenomeWeb) – Israeli biotech firm MeMed said that it has won a €2.3 million ($2.6 million) grant from the European Commission to support clinical testing of its ImmunoXpert test, a protein diagnostic for distinguishing between bacterial and viral infections.

According to the company, the funds will be used to put the test in pediatric departments in Italy and Germany. It aims to monitor 1,200 children with either respiratory tract infections or fevers without source, assessing both the clinical utility and cost-effectiveness of the test.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

Under a proposed spending bill, the US National Institutes of Health would see an additional $3 billion in funding.

Researchers from the University of Oxford and the University of Sydney sequenced numerous platypus genomes to study their population history.

Robert Redfield, the new pick to lead the US Centers for Disease Control and Prevention, has faced criticism for some of his work.

In Nature this week: sequenced genomes of five additional Neanderthals, and more.